Australian Dollar Holds Support Amid Mild Downside Bias Against US Dollar, Says UOB

Neutral (-0.2)Impact: Low

Published on June 30, 2026 (2 hours ago) · By Vibe Trader

Australian Dollar Holds Support Amid Mild Downside Bias Against US Dollar, Says UOB

According to United Overseas Bank’s (UOB) Quek Ser Leang, the Australian Dollar (AUD) remains under mild downward pressure against the US Dollar (USD), following a session characterized by a narrow trading range. The intraday bias for AUD/USD is tilted to the downside, but any decline is expected to be contained within the 0.6865–0.6900 range, with a clear break below 0.6865 seen as unlikely at this stage [1].

In the previous session, AUD/USD traded within a range of 0.6878 to 0.6904 and closed largely unchanged at 0.6886, representing a marginal decrease of 0.06%. UOB maintains that while there is a slight increase in downward momentum, the currency pair is unlikely to break decisively below the 0.6865 support level in the near term [1].

Looking at the 1–3 week outlook, UOB notes that downward momentum for the AUD is starting to ease. The bank highlights that a move above 0.6940 would negate downside targets, while the broader trend still points toward 0.6707. The current view is that unless there is a break above 0.6940, the downside remains in focus, but significant further declines are not anticipated in the immediate term [1].

No specific market reactions, analyst opinions beyond UOB’s, or additional forward-looking statements are provided in the article [1].

CONCLUSION

UOB’s analysis indicates that the Australian Dollar is experiencing mild downside pressure against the US Dollar, but key support levels are expected to hold in the near term. The outlook remains cautiously negative unless AUD/USD breaks above 0.6940, which would shift the bias. Market impact is assessed as low, with no major moves or reactions reported.

Turn today's news into tomorrow's trade.

Try Vibe Trader Free →

Feel free to email us at team@vibetrader@gmail.com

Was this page helpful?

Related Articles

Abivax Shares Surge 31% After New Data Eases Cancer Concerns for Lead Ulcerative Colitis Drug

Shares of French biotech company Abivax surged by 31% on Tuesday following the r...

Read more

ECB Officials Warn Inflation May Stay Above Target, Further Rate Hikes Possible

European Central Bank (ECB) policymakers have expressed concerns that inflation...

Read more

Euro Remains Weak Against Pound Despite Strong German Retail Sales Data

The EUR/GBP currency pair continued to trade in negative territory around 0.8605...

Read more